Elsevier,
Patterns, Volume 4, Issue 7, 2023, 100790, ISSN 2666-3899,
This Perspective explores the sources of bias in medical machine learning, and how these can contribute to unequal performance, for example for women. The authors discuss methods for mitigating bias, hopefully leading to more equitable use of machine learning in healthcare.
Elsevier,
The Lancet, Volume 402, 1 July 2023
This Health Policy paper supports SDG 3, 15, and 16 by highlighting how climate change and other human-induced environmental changes, such as loss of biodiversity and air pollution, disproportionately affect the health of minoritised people globally.
Elsevier,
Advances in Nutrition, Volume 14, July 2023
This review integrates the current evidence and potential mechanisms of gut microbiota and its metabolites in Alzheimer’s disease and comprehensively reviews the possibility of leveraging dietary interventions to prevent Alzheimer’s disease progression, with a focus on the gut–microbiota–brain connections and diet–metabolite–host interactions.
Elsevier,
Journal of Pharmaceutical Analysis, Volume 13, July 2023
The study reveals that damage to the blood-brain barrier increases the proportion of microglia, a type of brain cell, which contributes to the progression of aging and Alzheimer's disease. It also identifies ten different functional types of microglia and underscores the significance of certain signalling pathways in communication between cells.
Elsevier,
Neuroscience Letters, Volume 810, 27 July 2023
This article investigates the distribution and levels of tau and other neuronal proteins in the submandibular gland and frontal cortex of individuals at different clinicopathological stages of Alzheimer's disease (AD), revealing differential protein levels and the presence of unique tau species in peripheral tissues, providing insights into the relationship between peripheral tissues and AD progression.
